scorecardresearch
Sunday, November 3, 2024
TopicBharat Biotech

Topic: Bharat Biotech

Tackling India’s vaccine hesitancy, and Modi’s ‘world topper’ trophy

The best cartoons of the day, chosen by the editors at ThePrint.

After Congress’ Jairam & Tharoor, now Milind Deora questions ‘speedy’ approval for Covaxin

Milind Deora joins Shashi Tharoor and Jairam Ramesh in questioning ‘premature approval’ for Bharat Biotech’s Covaxin even though the Congress has officially welcomed the vaccine.

Those doubting Bharat Biotech’s efficacy mentally challenged, says Union minister Pradhan

Dharmendra Pradhan's remarks came after Congress leaders raised doubts on the approval of Bharat Biotech's vaccine, for restricted use, while its 3rd phase trial is still underway.

Thank you, Akhilesh Yadav. BJP can take its vaccine nationalism from here

Samajwadi Party chief Akhilesh Yadav erred big time with his ‘BJP’s vaccine’ comment. But it highlights how BJP is winning the battle of public perception in Covid management.

Submit Covaxin safety reports every 15 days, include mild side-effects — govt to Bharat Biotech

Drug regulator DCGI’s approval to Bharat Biotech’s Covaxin for emergency use is subject to certain conditions detailed in the ‘permission form’.

Congress questions why Bharat Biotech’s Covaxin was cleared without completing phase-3 trials

Congress’ Anand Sharma, head of parliamentary panel, says health ministry needs to explain sidestepping protocol because Covaxin will be given to frontline workers.

Covaxin approved as it’s more likely to act against mutant Covid strain, says ICMR chief

In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.

Covaxin & Covishield get govt nod for emergency use, stage set for Covid immunisation to begin

Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.

Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data

Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.

Everything you need to know about Covaxin, India’s controversial Covid vaccine candidate

Bharat Biotech's Covaxin has been recommended for restricted emergency use authorisation by an expert committee appointed by the Central Drugs Standard Control Organisation.

On Camera

As a Hindu Canadian, I am deeply hurt by cancellation of Diwali. My community is now sidelined

Canada faces serious foreign interference issues, but these challenges must not be weaponized to unfairly target friendly and important allies like India.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

Indian firms sanctioned by US didn’t violate laws, says MEA. Hyderabad firm that supplied to Army on list

Among 19 Indian firms sanctioned by US Treasury Dept was Lokesh Machines Ltd accused of coordinating with 'Russian defence procurement agent to import Italy-origin CNC machines'.

Xi wanted to teach India about imbalance of power. We should take a budgetary lesson from it

While we talk much about our military, we don’t put our national wallet where our mouth is. Nobody is saying we should double our defence spending, but current declining trend must be reversed.